These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 26299348

  • 21. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
    Eldehna WM, Fares M, Ibrahim HS, Aly MH, Zada S, Ali MM, Abou-Seri SM, Abdel-Aziz HA, Abou El Ella DA.
    Eur J Med Chem; 2015 Jul 15; 100():89-97. PubMed ID: 26071861
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.
    Fu W, Wang J, Yu L, Zhao L, Lu N, You Q, Guo Q, Li Z.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):1118-21. PubMed ID: 22196122
    [Abstract] [Full Text] [Related]

  • 23. Novel α, β-Unsaturated Sophoridinic Derivatives: Design, Synthesis, Molecular Docking and Anti-Cancer Activities.
    Xu Y, Wu L, Dai H, Gao M, Ur Rashid H, Wang H, Xie P, Liu X, Jiang J, Wang L.
    Molecules; 2017 Nov 14; 22(11):. PubMed ID: 29135958
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
    Dai M, Yuan X, Kang J, Zhu ZJ, Yue RC, Yuan H, Chen BY, Zhang WD, Liu RH, Sun QY.
    Eur J Med Chem; 2013 Nov 14; 69():159-66. PubMed ID: 24013415
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
    Leiris S, Lucas M, Dupuy d'Angeac A, Morère A.
    Eur J Med Chem; 2010 Sep 14; 45(9):4140-8. PubMed ID: 20615582
    [Abstract] [Full Text] [Related]

  • 26. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB, Wang XL, Liu W, Yang YS, Tang JF, Zhu HL.
    Bioorg Med Chem; 2012 Nov 01; 20(21):6356-65. PubMed ID: 23018096
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.
    Yang J, Liu Y, Xue C, Yu W, Zhang J, Qiao C.
    Eur J Med Chem; 2014 Oct 30; 86():235-41. PubMed ID: 25164762
    [Abstract] [Full Text] [Related]

  • 32. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
    Gorle S, Maddila S, Maddila SN, Naicker K, Singh M, Singh P, Jonnalagadda SB.
    Anticancer Agents Med Chem; 2017 Oct 30; 17(3):464-470. PubMed ID: 27357544
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
    Lan P, Wang J, Zhang DM, Shu C, Cao HH, Sun PH, Wu XM, Ye WC, Chen WM.
    Eur J Med Chem; 2011 Jun 30; 46(6):2490-502. PubMed ID: 21496972
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard.
    Papot S, Combaud D, Bosslet K, Gerken M, Czech J, Gesson JP.
    Bioorg Med Chem Lett; 2000 Aug 21; 10(16):1835-7. PubMed ID: 10969980
    [Abstract] [Full Text] [Related]

  • 35. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G, Chen M, Lyu W, Zhao R, Xu Q, You Q, Xiang H.
    Bioorg Med Chem Lett; 2017 Jun 15; 27(12):2668-2673. PubMed ID: 28460819
    [Abstract] [Full Text] [Related]

  • 36. Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.
    Ma J, Chen D, Lu K, Wang L, Han X, Zhao Y, Gong P.
    Eur J Med Chem; 2014 Oct 30; 86():257-69. PubMed ID: 25171780
    [Abstract] [Full Text] [Related]

  • 37. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W, Chen L, Li HM, Wang DJ, Li DS, Chen T, Yuan ZP, Tang YJ.
    Bioorg Med Chem; 2014 Jun 01; 22(11):2998-3007. PubMed ID: 24775914
    [Abstract] [Full Text] [Related]

  • 38. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB, Tang WJ, Qi XB, Li R, Liu XH.
    Eur J Med Chem; 2015 Jan 27; 90():889-96. PubMed ID: 25554922
    [Abstract] [Full Text] [Related]

  • 39. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L, Wu TT, Wang Z, Xue JY, Xu YG.
    Eur J Med Chem; 2014 Sep 12; 84():698-707. PubMed ID: 25064347
    [Abstract] [Full Text] [Related]

  • 40. Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.
    Xie W, Xie S, Zhou Y, Tang X, Liu J, Yang W, Qiu M.
    Eur J Med Chem; 2014 Jun 23; 81():22-7. PubMed ID: 24819956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.